OBESE
Clinical trials for OBESE explained in plain language.
Never miss a new study
Get alerted when new OBESE trials appear
Sign up with your email to follow new studies for OBESE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Weight-Loss drug SA030 enters first human safety trial
Disease control Not yet recruitingThis study is the first time the experimental drug SA030 is being tested in people. It aims to check the safety and how the body handles a single dose in 40 overweight or obese adults aged 18 to 55. Participants will be randomly assigned to receive either SA030 or a placebo, and …
Matched conditions: OBESE
Phase: PHASE1 • Sponsor: Suzhou Siran Biotechnology Co.,Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New supplement MB-1 aims to help overweight adults shed pounds
Disease control Not yet recruitingThis study tests if a supplement called MB-1 can help overweight and obese adults lose weight safely. One hundred adults with a BMI between 25 and 34.9 will take either MB-1 or a placebo for 84 days. Researchers will measure changes in body weight, BMI, and other health markers t…
Matched conditions: OBESE
Phase: NA • Sponsor: Arrae • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
Kidney function may affect new Weight-Loss drug
Knowledge-focused Not yet recruitingThis early-stage study tests a single shot of HDM1005 in 30 people, some with kidney impairment and some healthy. The goal is to see how the drug moves through the body and if it is safe. Results will help guide future dosing for people with kidney issues.
Matched conditions: OBESE
Phase: PHASE1 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC